OptiNose(OPTN) - 2023 Q3 - Earnings Call Presentation

Building a Leading ENT / Allergy Specialty Company C or porate P resentation N ove m be r 9, 2023 Forward-Looking Statements This presentation and our accompanying remarks contain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statements for this purpose and include, among others, statements relating to: the generation of XHANCE prescriptions and net revenues a ...